Protective effect of the omega-3 polyunsaturated fatty acids: Eicosapentaenoic acid/Docosahexaenoic acid 1:1 ratio on cardiovascular disease risk markers in rats

Laura Lluís, Núria Taltavull, Mònica Muñoz-Cortés, Vanesa Sánchez-Martos, Marta Romeu, Montse Giralt, Eunice Molinar-Toribio, Josep Lluís Torres, Jara Pérez-Jiménez, Manuel Pazos, Lucía Méndez, José M Gallardo, Isabel Medina, M Rosa Nogués, Laura Lluís, Núria Taltavull, Mònica Muñoz-Cortés, Vanesa Sánchez-Martos, Marta Romeu, Montse Giralt, Eunice Molinar-Toribio, Josep Lluís Torres, Jara Pérez-Jiménez, Manuel Pazos, Lucía Méndez, José M Gallardo, Isabel Medina, M Rosa Nogués

Abstract

Background: High consumption of fish carries a lower risk of cardiovascular disease as a consequence of dietary omega-3 long chain polyunsaturated fatty acid (n-3 PUFA; especially EPA and DHA) content. A controversy exists about the component/s responsible of these beneficial effects and, in consequence, which is the best proportion between both fatty acids. We sought to determine, in healthy Wistar rats, the proportions of EPA and DHA that would induce beneficial effects on biomarkers of oxidative stress, and cardiovascular disease risk.

Methods: Female Wistar rats were fed for 13 weeks with 5 different dietary supplements of oils; 3 derived from fish (EPA/DHA ratios of 1:1, 2:1, 1:2) plus soybean and linseed as controls. The activities of major antioxidant enzymes (SOD, CAT, GPX, and GR) were determined in erythrocytes and liver, and the ORAC test was used to determine the antioxidant capacity in plasma. Also measured were: C reactive protein (CRP), endothelial dysfunction (sVCAM and sICAM), prothrombotic activity (PAI-1), lipid profile (triglycerides, cholesterol, HDLc, LDLc, Apo-A1, and Apo-B100), glycated haemoglobin and lipid peroxidation (LDL-ox and MDA values).

Results: After three months of nutritional intervention, we observed statistically significant differences in the ApoB100/ApoA1 ratio, glycated haemoglobin, VCAM-1, SOD and GPx in erythrocytes, ORAC values and LDL-ox. Supplementation with fish oil derived omega-3 PUFA increased VCAM-1, LDL-ox and plasma antioxidant capacity (ORAC). Conversely, the ApoB100/ApoA1 ratio and percentage glycated haemoglobin decreased.

Conclusions: Our results showed that a diet of a 1:1 ratio of EPA/DHA improved many of the oxidative stress parameters (SOD and GPx in erythrocytes), plasma antioxidant capacity (ORAC) and cardiovascular risk factors (glycated haemoglobin) relative to the other diets.

References

    1. Ackman RG. Biogenic Lipids Fats and Oils. Boca Ratón. Florida: CRC Press; 1989.
    1. Mozaffarian D, Wu JH. (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? J Nutr. doi:10.3945/jn.111.149633.
    1. Aguilera AA, Diaz GH, Barcelata ML, Guerrero OA, Ros RM. Effects of fish oil on hypertension, plasma lipids, and tumor necrosis factor-alpha in rats with sucrose induced metabolic syndrome. J Nutr Biochem. 2004;15:350–357. doi: 10.1016/j.jnutbio.2003.12.008.
    1. Dyerberg J. Platelet - vessel wall interaction: Influence of diet. Philos Trans R Soc Lond B Biol Sci. 1981;294:373–381. doi: 10.1098/rstb.1981.0113.
    1. Poudyal H, Panchal SK, Diwan V, Brown L. Omega-3 fatty acids and metabolic syndrome: Effects and emerging mechanisms of action. Prog Lipid Res. 2011;50:372–387. doi: 10.1016/j.plipres.2011.06.003.
    1. Armitage JA, Pearce AD, Sinclair AJ, Vingrys AJ, Weisinger RS, Weisinger HS. Increased blood pressure later in life may be associated with perinatal n-3 fatty acid deficiency. Lipids. 2003;38:459–464. doi: 10.1007/s11745-003-1084-y.
    1. Sener A, Zhang Y, Bulur N, Louchami K, Malaisse WJ, Carpentier YA. The metabolic syndrome of omega3-depleted rats. II. Body weight, adipose tissue mass and glycemic homeostasis. Int J Mol Med. 2009;24:125–129.
    1. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA. 1991;88:10045–10048. doi: 10.1073/pnas.88.22.10045.
    1. Urso C, Hopps E, Caimi G. Adhesion molecules and diabetes mellitus. Clin Ter. 2010;161:e17–e24.
    1. Dubnov G, Berry EM. Omega-6/omega-3 fatty acid ratio: the Israeli paradox. World Rev Nutr Diet. 2003;92:81–91.
    1. Ginty AT, Conklin SM. Preliminary evidence that acute long-chain omega-3 supplementation reduces cardiovascular reactivity to mental stress: a randomized and placebo controlled trial. Biol Psychol. 2012;89:269–272. doi: 10.1016/j.biopsycho.2011.09.012.
    1. Schuchardt JP, Neubronner J, Kressel G, Merkel M, von Schacky C, Hahn A. Moderate doses of EPA and DHA from re-esterified triacylglycerols but not from ethyl esters lower fasting serum triacylglycerols in statin-treated dyslipidemic subjects: results from a six month randomized controlled trial. Prostaglandins Leukot Essent Fatty Acids. 2011;85:381–386. doi: 10.1016/j.plefa.2011.07.006.
    1. Méndez L, Pazos M, Gallardo JM, Torres JL, Pérez-Jimenez J, Nogués R, Romeu M, Medina I. Reduced protein oxidation in Wistar rats supplemented with marine ω-3 PUFAs. Free Radic Biol Med. 2013;55:8–20.
    1. Levy E, Brunet S, Alvarez F, Seidman E, Bouchard G, Escobar E, Martin S. Abnormal hepatobiliary and circulating lipid metabolism in the Long-Evans Cinnamon rat model of Wilson’s disease. Life Sci. 2007;80:1472–1483. doi: 10.1016/j.lfs.2007.01.017.
    1. Rusinol AE, Lysak PS, Sigurdson GT, Vance JE. Monomethylethanolamine reduces plasma triacylglycerols and apolipoprotein B and increases apolipoprotein A-I rats without induction of fatty liver. J Lipid Res. 1996;37:2296–2304.
    1. Yessoufou A, Soulaimann N, Merzouk SA, Moutairou K, Ahissou H, Prost J, Simonin AM, Merzouk H, Hichami A, Khan NA. N-3 fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring. Int J Obes (Lond) 2006;30:739–750. doi: 10.1038/sj.ijo.0803211.
    1. El-Seweidy MM, Sadik NA, Shaker OG. Role of sulfurous mineral water and sodium hydrosulfide as potent inhibitors of fibrosis in the heart of diabetic rats. Arch Biochem Biophys. 2011;506:48–57. doi: 10.1016/j.abb.2010.10.014.
    1. Hassanali Z, Ametaj BN, Field CJ, Proctor SD, Vine DF. Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR: LA-cp rat. Diabetes Obes Metab. 2010;12:139–147. doi: 10.1111/j.1463-1326.2009.01130.x.
    1. Shah KB, Duda MK, O’Shea KM, Sparagna GC, Chess DJ, Khairallah RJ, Robillard-Frayne I, Xu W, Murphy RC, Des Rosiers C, Stanley WC. The cardioprotective effects of fish oil during pressure overload are blocked by high fat intake: Role of cardiac phospholipid remodeling. Hypertension. 2009;54:605–611. doi: 10.1161/HYPERTENSIONAHA.109.135806.
    1. EFSA. Scientific Opinion on the substantiation of health claims related to eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and maintenance of normal cardiac function, maintenance of normal blood glucose concentrations, maintenance of normal blood pressure, maintenance of normal blood HDL-cholesterol concentrations, maintenance of normal (fasting) blood concentrations of triglycerides. EFSA J. 2010;8:1796.
    1. Romieu I, Garcia-Esteban R, Sunyer J, Rios C, Alcaraz-Zubeldia M, Velasco SR, Holguin F. The effect of supplementation with omega-3 polyunsaturated fatty acids on markers of oxidative stress in elderly exposed to PM (2.5) Environ Health Perspect. 2008;116:1237–1242. doi: 10.1289/ehp.10578.
    1. Grim JM, Hyndman KA, Kriska T, Girotti AW, Crockett EL. Relationship between oxidizable fatty acid content and level of antioxidant glutathione peroxidases in marine fish. J Exp Biol. 2011;214:3751–3759. doi: 10.1242/jeb.058214.
    1. Lapointe A, Couillard C, Lemieux S. Effects of dietary factors on oxidation of low density lipoprotein particles. J Nutr Biochem. 2006;17:645–658. doi: 10.1016/j.jnutbio.2006.01.001.
    1. Kirimlioglu V, Kirimlioglu H, Yilmaz S, Ozgor D, Coban S, Karadag N, Yologlu S. Effect of fish oil, olive oil, and vitamin E on liver pathology, cell proliferation, and antioxidant defense system in rats subjected to partial hepatectomy. Transplant Proc. 2006;38:564–567. doi: 10.1016/j.transproceed.2006.02.005.
    1. Hussein O, Grosovski M, Lasri E, Svalb S, Ravid U, Assy N. Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats. World J Gastroenterol. 2007;13:361–368.
    1. Ferreira L, Teixeira-de-Lemos E, Pinto F, Parada B, Mega C, Vala H, Pinto R, Garrido P, Sereno J, Fernandes R, Santos P, Velada I, Melo A, Nunes S, Teixeira F, Reis F. Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat) Mediators Inflamm. 10.1155/2010/592760.
    1. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972;247(10):3170–3175.
    1. Cohen G, Dembiec D, Marcus J. Measurement of catalase activity in tissue extracts. Anal Biochem. 1970;34:30–38. doi: 10.1016/0003-2697(70)90083-7.
    1. Wheeler CR, Salzman JA, Elsayed NM, Omaye ST, Korte DW Jr. Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity. Anal Biochem. 1990;184:193–199. doi: 10.1016/0003-2697(90)90668-Y.
    1. Goldberg DM, Spooner RJ. In: Methods of enzymatic analysis. 3. Bergmeyer HU, editor. Weinheim, Germany: Verlag Chemie; 1983. Glutathione reductase; pp. 258–265.
    1. Cao G, Booth SL, Sadowski JA, Prior RL. Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables. Am J Clin Nutr. 1998;68:1081–1087.
    1. Mateos R, Lecumberri E, Ramos S, Goya L, Bravo L. Determination of malondialdehyde (MDA) by high-performance liquid chromatography in serum and liver as a biomarker for oxidative stress. Application to a rat model for hypercholesterolemia and evaluation of the effect of diets rich in phenolic antioxidants from fruits. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;827:76–82. doi: 10.1016/j.jchromb.2005.06.035.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera